Sort
16,300 grants matching “fatty liver disease”
Mapping the Glucuronidome
$35,738Nina Boyle · Pennsylvania State University, The · F31 · FY2023 · DK
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network
$35,650Norah A. Terrault · University Of California, San Francisco · U01 · FY2013 · DK
Investigation of NADPH oxidase as a link between vascular and metabolic dysfunction
$35,648Cesar Meza · Florida State University · F31 · FY2021 · HL
Nonalcoholic steatohepatitis as a potential contributor to individual susceptibility to tetrachloroethylene-associated toxicity
$35,636Joseph Cichocki · Texas A&M University · F32 · FY2016 · ES
Identification of lipid biomarkers via integrative genomic approaches in Hispanic populations
$35,621Arthur Ko · University Of California Los Angeles · F31 · FY2017 · HL
The role of dietary cholesterol in Nonalcoholic fatty liver disease through the action of gut microbiota
$35,583Jake Brenner Hermanson · University Of Wisconsin-Madison · F31 · FY2023 · DK
Evaluating the impact of obesity-associated inflammation on breast cancer heterogeneity and metastasis using single-cell RNA-seq
$35,564Shannon Bruce McDonell · Univ Of North Carolina Chapel Hill · F30 · FY2019 · CA
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
$35,530Zachary A Kipp · University Of Kentucky · F31 · FY2025 · HL
Summer Endocrine Research Training Program
$35,527Carolyn M. Klinge · University Of Louisville · T35 · FY2016 · DK
Regulation of the innate immune response in alcoholic liver disease by autophagy
$35,515Mark J. Czaja · Albert Einstein College Of Medicine · R01 · FY2015 · AA
Roles for FoxO proteins in human liver development
$35,483Karen E Giles · Medical College Of Wisconsin · F30 · FY2017 · DK
Methionine Aminopeptidase 2 Regulates Lipid Metabolism in Peripheral Tissues
$35,229Christy M Gliniak · Ut Southwestern Medical Center · F32 · FY2021 · DK
Tunable Synthetic ECMs for Investigating Stellate Cell Activation and Migration
$35,229Matthew David Davidson · University Of Pennsylvania · F32 · FY2021 · DK
Regulation of de novo lipogenesis through BAD-dependent glucose signaling
$35,225Elizabeth Lane · Harvard Medical School · F31 · FY2015 · DK
Pathogenic Mechanisms of Fatty Liver Disease
$35,199Mohammad S Siddiqui · Northwestern University At Chicago · F32 · FY2011 · DK
SAR and Biosynthetic Origins of PAHSAs, a Novel Family of Anti-Diabetic Lipids
$35,176Andrew T Nelson · University Of Texas Med Br Galveston · F30 · FY2019 · DK
Identification of lipid biomarkers via integrative genomic approaches in Hispanic populations
$35,153Arthur Ko · University Of California Los Angeles · F31 · FY2016 · HL
Chemerin stimulation of vascular function in support of blood pressure
$35,098David Ferland · Michigan State University · F31 · FY2019 · HL
Alcoholic Liver Dysfunction Potentiation by Hyperlipidemia and Cigarette Smoke
$35,000Shannon Marie Bailey · University Of Alabama At Birmingham · R01 · FY2010 · AA
2025 Cancer Cachexia Conference: Cachexia management today and potential treatments for tomorrow
$35,000Andrew Robert Judge · University Of Florida · R13 · FY2025 · CA
HIV and Liver Disease Conference
$35,000Kenneth E Sherman · University Of Cincinnati · R13 · FY2023 · AI
Patient-Oriented Research of Liver Disease
$34,938Naga P. Chalasani · Indiana University Indianapolis · K24 · FY2010 · DK
Elucidating the role of hepatic mTORC2 as a key regulator of carbohydrate metabolism in non-alcoholic fatty liver disease
$34,900John Anthony Haley · Univ Of Massachusetts Med Sch Worcester · F31 · FY2023 · DK
Xenobiotic-responsive hepatic long non-coding RNAs
$34,889David J Waxman · Boston University (Charles River Campus) · R01 · FY2023 · ES
sEH Inhibition in Alcoholic Liver Disease: A Novel Therapeutic Strategy
$34,826Jeffrey B Warner · University Of Louisville · F31 · FY2020 · AA